相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Pain Centralization and Patient-Reported Pain in Active Rheumatoid Arthritis
Andrew C. Heisler et al.
ARTHRITIS CARE & RESEARCH (2020)
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Gerd R Burmester et al.
LANCET (2020)
Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis A single-center, randomized, double-blind clinical trial
Li Hua et al.
MEDICINE (2020)
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib
Vibeke Strand et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Glucocorticoids in rheumatoid arthritis: current status and future studies
Charlotte Hua et al.
RMD OPEN (2020)
Central sensitization predicts greater fatigue independently of musculoskeletal pain
Katie L. Druce et al.
RHEUMATOLOGY (2019)
Patient-Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target
Kristien Van der Elst et al.
ARTHRITIS CARE & RESEARCH (2019)
Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking
Beth I. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The impact of anxiety on chronic musculoskeletal pain and the role of astrocyte activation
James J. Burston et al.
PAIN (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
Frank Buttgereit et al.
RMD OPEN (2019)
Effectiveness of methotrexate with step-down glucocorticoid remission induction ( COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
Patrick Verschueren et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study
Thomas Stock et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial
Faith Matcham et al.
RHEUMATOLOGY (2016)
Factors predicting pain and early discontinuation of tumour necrosis factor α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register
Daniel F. McWilliams et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Erosive and osteoarthritic structural progression in early rheumatoid arthritis
Daniel F. McWilliams et al.
RHEUMATOLOGY (2016)
Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis
I. C. Scott et al.
RMD OPEN (2016)
A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis
Nalinie Joharatnam et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis
Rieke Alten et al.
RMD OPEN (2015)
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
Frank Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis A Randomized Trial
Marije F. Bakker et al.
ANNALS OF INTERNAL MEDICINE (2012)
Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study
Carlomaurizio Montecucco et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis
Lynsey Clarke et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Patient Perceptions Concerning Pain Management in the Treatment of Rheumatoid Arthritis
P. Taylor et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Circadian versus Ultradian Glucocorticoid Regimen in the Treatment of Rheumatoid Arthritis
R. Alten et al.
AKTUELLE RHEUMATOLOGIE (2009)
Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial
T. Pincus et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial
Frank Buttgereit et al.
LANCET (2008)
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis
E. H. S. Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs
EH Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
The clinical effect of Glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies
AA Van Everdingen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale
F Salaffi et al.
EUROPEAN JOURNAL OF PAIN (2004)
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis
JR Kirwan et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide
P Sheldon
RHEUMATOLOGY INTERNATIONAL (2003)
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects - A randomized, double-blind, placebo-controlled clinical trial
AA van Everdingen et al.
ANNALS OF INTERNAL MEDICINE (2002)
分享论文
